AcquirerTargetPrice
Novartis AGCerulean’s Dynamic Tumor Targeting platform$6 million
JPB Capital PartnersHometown Hospice and Homecare, Inc.N/A
Daré BioscienceCerulean Pharma Inc.Merger
AlliarMultiscan Imagem e Diagnostico$29.3 million